Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to form biaryl compounds. Its pyridine and morpholine moieties enhance solubility and binding properties, making it valuable in the development of kinase inhibitors and other bioactive molecules. Commonly employed in medicinal chemistry for constructing drug candidates targeting cancer, inflammation, and central nervous system disorders. The boronate ester group allows for efficient and selective coupling under mild conditions, ideal for late-stage functionalization in complex molecule assembly.